NAME

Question types


Start with


Question limit

of 60 available terms

Advertisement Upgrade to remove ads
Print test

5 Written questions

5 Matching questions

  1. 2411.04
  2. 2407.01
  3. 2404.01
  4. 2406
  5. 2411.03
  1. a Application in Condition for Allowance Except for Deposit

    As set forth in 37 CFR 1.809(c), in the event that an application for patent is otherwise in condition for allowance except for a required deposit and the Office has received a written assurance that an acceptable deposit will be made, applicant will be notified and given a period of time within which the deposit must be made in order to avoid abandonment of the application for failure to prosecute the application under 35 U.S.C. 133
  2. b Time of Making an Original Deposit
  3. c After Patent Has Been Granted
  4. d Replacement or Supplement of Deposit
    IN A PENDING APPLICATION
  5. e Biological Material That Is Known and Readily Available to the Public

5 Multiple choice questions

  1. The Requirement for Exclusive Conformance; Sequences Presented in Drawing Figures
  2. Examination of Patent Applications Claiming Large Numbers of Nucleotide Sequences

    Nucleotide sequences encoding different proteins are structurally distinct chemical compounds and are unrelated to one another. These sequences are thus deemed to normally constitute independent and distinct inventions within the meaning of 35 U.S.C. 121. Absent evidence to the contrary, each such nucleotide sequence is presumed to represent an independent and distinct invention, subject to a restriction requirement pursuant to 35 U.S.C. 121 and 37 CFR 1.141.

    applicants may petition pursuant to 37 CFR 1.181 for examination of additional nucleotide sequences by providing evidence that the different nucleotide sequences do not cover independent and distinct inventions.
  3. Sequence Listing Numeric Identifiers
  4. Acceptable Depository

    The depository must:
    (i)Have a continuous existence;
    (ii)Exist independent of the control of the depositor;
    (iii)Possess the staff and facilities sufficient to examine the viability of a deposit and store the deposit in a manner which ensures that it is kept viable and uncontaminated;
    (iv)Provide for sufficient safety measures to minimize the risk of losing biological material deposited with it;
    (v)Be impartial and objective;
    (vi)Furnish samples of the deposited material in an expeditious and proper manner; and
    (vii)Promptly notify depositors of its inability to furnish samples, and the reasons why.
  5. Future Changes to the Sequence Rules

5 True/False questions

  1. 2422.06Reference to Previously Filed Identical Computer Readable Form; Continuing or Dericatiove Applications; Request for Transfer of Computer Readable Form

          

  2. 2403.01Description in Application Specification
    37 CFR 1.804(a)
    requirement for a specific identification consistent with the description requirement of the first paragraph of 35 U.S.C. 112 and provides an antecedent basis for the biological material which either has been or will be deposited before the patent is granted.

          

  3. 2422.09Box Sequence; Hand Delivery of Sequence Listings and Computer Readable Forms

          

  4. 2422.07Reference to Previously Filed Identical Computer Readable Form; Continuing or Dericatiove Applications; Request for Transfer of Computer Readable Form

          

  5. 2409Viability of Deposit

    Viability may be tested by the depository. The test must conclude only that the deposited material is capable of reproduction. No evidence is necessarily required regarding the ability of the deposited material to perform any function described in the patent application.

          

Create Set